Pirjo Laakkonen

8.5k total citations · 1 hit paper
86 papers, 5.8k citations indexed

About

Pirjo Laakkonen is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Pirjo Laakkonen has authored 86 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 35 papers in Oncology and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Pirjo Laakkonen's work include Monoclonal and Polyclonal Antibodies Research (18 papers), Glioma Diagnosis and Treatment (13 papers) and Cell Adhesion Molecules Research (11 papers). Pirjo Laakkonen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (18 papers), Glioma Diagnosis and Treatment (13 papers) and Cell Adhesion Molecules Research (11 papers). Pirjo Laakkonen collaborates with scholars based in Finland, United States and Sweden. Pirjo Laakkonen's co-authors include Erkki Ruoslahti, Kimmo Porkka, Warren C. W. Chan, Sangeeta N. Bhatia, Jason A. Hoffman, Leevi Kääriäinen, Vadim Le Joncour, Michele Bernasconi, Tero Ahola and Johan Peränen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Pirjo Laakkonen

84 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanocrystal targeting in vivo

2002 1.0k citations Pirjo Laakkonen et al. profile →

Peers

Pirjo Laakkonen

ONCOL

BIOMA

Tambet Teesalu Estonia

Pin Wang United States

Kazuki N. Sugahara United States

Steve R. Roffler Taiwan

Luis J. Cruz Netherlands

Enrico Mastrobattista Netherlands

Stephen J. Kennel United States

Manuel L. Penichet United States

Martin C. Woodle United States

Esther H. Chang United States

Tambet Teesalu Estonia

Pirjo Laakkonen

4.3k ×1.3

1.2k ×0.8

ONCOL

2.1k ×2.3

2.1k ×2.6

BIOMA

475 ×0.6

Citations per year, relative to Pirjo Laakkonen Pirjo Laakkonen (= 1×) peers Tambet Teesalu

Countries citing papers authored by Pirjo Laakkonen

Since Specialization

Citations

This map shows the geographic impact of Pirjo Laakkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pirjo Laakkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pirjo Laakkonen more than expected).

Fields of papers citing papers by Pirjo Laakkonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pirjo Laakkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pirjo Laakkonen. The network helps show where Pirjo Laakkonen may publish in the future.

Co-authorship network of co-authors of Pirjo Laakkonen

This figure shows the co-authorship network connecting the top 25 collaborators of Pirjo Laakkonen. A scholar is included among the top collaborators of Pirjo Laakkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pirjo Laakkonen. Pirjo Laakkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergström, C, et al.. (2025). Deciphering the Dialogue between Brain Tumors, Neurons, and Astrocytes. American Journal Of Pathology. 195(7). 1193–1208. 2 indexed citations

Airenne, Tomi T., Xiaoqing Zhuang, Heidi Liljenbäck, et al.. (2025). Utilizing Monocarboxylate Transporter 1-Mediated Blood–Brain Barrier Penetration for Glioblastoma Positron Emission Tomography Imaging with 6-[¹⁸F]Fluoronicotinic Acid. Molecular Pharmaceutics. 22(8). 4819–4830. 1 indexed citations

Joncour, Vadim Le, György Vereb, Jorma Isola, et al.. (2025). Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan. Translational Oncology. 53. 102284–102284. 1 indexed citations

Monzó, Héctor J., Marko Hyytiäinen, Lidia Moyano‐Galceran, et al.. (2023). Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model. Molecular Cancer Therapeutics. 22(11). 1319–1331. 14 indexed citations

Joncour, Vadim Le, et al.. (2022). Bivalent EGFR-Targeting DARPin-MMAE Conjugates. International Journal of Molecular Sciences. 23(5). 2468–2468. 12 indexed citations

Prabhakar, Neeraj, Vadim Le Joncour, Markus Peurla, et al.. (2021). Circumventing Drug Treatment? Intrinsic Lethal Effects of Polyethyleneimine (PEI)-Functionalized Nanoparticles on Glioblastoma Cells Cultured in Stem Cell Conditions. Cancers. 13(11). 2631–2631. 11 indexed citations

Laakkonen, Pirjo, et al.. (2021). Peptide-Based Strategies for Targeted Tumor Treatment and Imaging. Pharmaceutics. 13(4). 481–481. 54 indexed citations

Munne, Pauliina, Ilida Suleymanova, Johanna I. Englund, et al.. (2021). Hepsin regulates TGFβ signaling via fibronectin proteolysis. EMBO Reports. 22(11). e52532–e52532. 12 indexed citations

Tonali, Nicolò, Julia Kaffy, Vadim Le Joncour, et al.. (2021). Peptidotriazolamers Inhibit Aβ(1–42) Oligomerization and Cross a Blood‐Brain‐Barrier Model. ChemPlusChem. 86(6). 840–851. 4 indexed citations

10.

Granberg, Kirsi J., Erika Gucciardo, Hannu Haapasalo, et al.. (2021). CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity. JCI Insight. 6(9). 37 indexed citations

11.

Sihto, Harri, József Tóvári, Lilla Reiniger, et al.. (2020). Prostate‐specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain. Journal of Cellular and Molecular Medicine. 24(12). 6916–6927. 12 indexed citations

12.

Sewald, Norbert, et al.. (2020). Tumor-Targeting Peptides: The Functional Screen of Glioblastoma Homing Peptides to the Target Protein FABP3 (MDGI). Cancers. 12(7). 1836–1836. 10 indexed citations

13.

Joncour, Vadim Le, Daniela Modena, Paolo Pagani, et al.. (2019). Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics. 11(5). 220–220. 22 indexed citations

14.

Joncour, Vadim Le, Maija Hyvönen, Minna Holopainen, et al.. (2019). Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization. EMBO Molecular Medicine. 11(6). 42 indexed citations

15.

Joncour, Vadim Le, Maija Puhka, Jorma Isola, et al.. (2019). A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine. Molecular Cancer Therapeutics. 18(10). 1721–1730. 71 indexed citations

16.

Gebreyohannes, Yemarshet K., Agnieszka Woźniak, Olli Tynninen, et al.. (2018). Anagrelide for Gastrointestinal Stromal Tumor. Clinical Cancer Research. 25(5). 1676–1687. 19 indexed citations

17.

Kaur, Amanpreet, Oxana V. Denisova, Emilia Peuhu, et al.. (2016). PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells. Cancer Research. 76(23). 7001–7011. 38 indexed citations

18.

Hyvönen, Maija, Juulia Enbäck, Tuulia Huhtala, et al.. (2014). Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors. Molecular Cancer Therapeutics. 13(4). 996–1007. 44 indexed citations

19.

Rivinoja, Antti, Johan Lundin, Maija Hyvönen, et al.. (2011). An Extensive Tumor Array Analysis Supports Tumor Suppressive Role for Nucleophosmin in Breast Cancer. American Journal Of Pathology. 179(2). 1004–1014. 27 indexed citations

20.

Laakkonen, Pirjo, Marika Waltari, Tanja Holopainen, et al.. (2007). Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth. Cancer Research. 67(2). 593–599. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact